389 related articles for article (PubMed ID: 18973852)
1. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
Wang X; Krishnan S; Zhang X; Dong L; Briere T; Crane CH; Martel M; Gillin M; Mohan R; Beddar S
Med Dosim; 2008; 33(4):259-67. PubMed ID: 18973852
[TBL] [Abstract][Full Text] [Related]
2. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
3. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
6. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
Baumert BG; Norton IA; Lomax AJ; Davis JB
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
[TBL] [Abstract][Full Text] [Related]
7. A treatment planning comparison of combined photon-proton beams versus proton beams-only for the treatment of skull base tumors.
Feuvret L; Noel G; Weber DC; Pommier P; Ferrand R; De Marzi L; Dhermain F; Alapetite C; Mammar H; Boisserie G; Habrand JL; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):944-54. PubMed ID: 17889276
[TBL] [Abstract][Full Text] [Related]
8. Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy.
Hillbrand M; Georg D; Gadner H; Pötter R; Dieckmann K
Radiother Oncol; 2008 Nov; 89(2):141-9. PubMed ID: 18692928
[TBL] [Abstract][Full Text] [Related]
9. Can protons improve SBRT for lung lesions? Dosimetric considerations.
Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
[TBL] [Abstract][Full Text] [Related]
10. Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours.
Petersen JB; Lassen Y; Hansen AT; Muren LP; Grau C; Høyer M
Acta Oncol; 2011 Aug; 50(6):823-8. PubMed ID: 21767180
[TBL] [Abstract][Full Text] [Related]
11. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
12. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Kozak KR; Adams J; Krejcarek SJ; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):179-86. PubMed ID: 19019562
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy for neoadjuvant treatment of gastric cancer.
Knab B; Rash C; Farrey K; Jani AB
Med Dosim; 2006; 31(4):292-7. PubMed ID: 17134669
[TBL] [Abstract][Full Text] [Related]
14. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.
Arvold ND; Niemierko A; Broussard GP; Adams J; Fullerton B; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e495-500. PubMed ID: 22285662
[TBL] [Abstract][Full Text] [Related]
15. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
16. Plan robustness in proton beam therapy of a childhood brain tumour.
Lassen-Ramshad Y; Vestergaard A; Muren LP; Høyer M; Petersen JB
Acta Oncol; 2011 Aug; 50(6):791-6. PubMed ID: 21767176
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.
Vargas C; Fryer A; Mahajan C; Indelicato D; Horne D; Chellini A; McKenzie C; Lawlor P; Henderson R; Li Z; Lin L; Olivier K; Keole S
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):744-51. PubMed ID: 17904306
[TBL] [Abstract][Full Text] [Related]
18. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
Yock T; Schneider R; Friedmann A; Adams J; Fullerton B; Tarbell N
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1161-8. PubMed ID: 15950401
[TBL] [Abstract][Full Text] [Related]
19. Dose escalation with proton or photon radiation treatment for pancreatic cancer.
Bouchard M; Amos RA; Briere TM; Beddar S; Crane CH
Radiother Oncol; 2009 Aug; 92(2):238-43. PubMed ID: 19454367
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of movement-induced dose reduction in target volume: a comparison between photon and proton beam treatment.
Yoon M; Shin D; Kwak J; Park S; Lim YK; Kim D; Park SY; Lee SB; Shin KH; Kim TH; Cho KH
Med Dosim; 2009; 34(3):191-201. PubMed ID: 19647628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]